EXTX — Exact Therapeutics AS Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- NOK401.57m
- NOK275.46m
Annual cashflow statement for Exact Therapeutics AS, fiscal year end - December 31st, millions except per share.
2017 December 31st | 2018 December 31st | R2019 December 31st | 2020 December 31st | |
|---|---|---|---|---|
| Period Length: | — | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | |
| Standards: | — | NAS | IFRS | IFRS |
| Status: | fx Preliminary | Final | Final | Final |
| Net Income/Starting Line | — | -7.59 | -14.8 | -33.1 |
| Depreciation | ||||
| Non-Cash Items | — | — | -0.318 | 7.34 |
| Other Non-Cash Items | ||||
| Changes in Working Capital | — | -4.78 | 2.28 | -1.15 |
| Change in Accounts Receivable | ||||
| Change in Accounts Payable | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | — | -12.2 | -12.5 | -26 |
| Capital Expenditures | — | 0 | -1.4 | -3.96 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | — | — | -21.6 | 2.98 |
| Acquisition of Business | ||||
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | — | 0 | -23 | -0.981 |
| Financing Cash Flow Items | — | — | -0.01 | -3.8 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | — | 56.3 | -0.114 | 143 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | — | 44.1 | -35.5 | 115 |